MONALEESA Trial: The Study That Quietly Rewrote Survival in HR-Positive Metastatic Breast Cancer
For years, hormone receptor–positive (HR+) metastatic breast cancer was described as “indolent.” It wasn’t. It was slower than…
Browsing Tag